Transarterial Chemoembolization of Liver Metastases from Well Differentiated Gastroenteropancreatic Endocrine Tumors with Doxorubicin-eluting Beads: Preliminary Results

Tomassetti, 2001, Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours, Ann Oncol, 12, S95, 10.1023/A:1012468409003

Pape, 2004, Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center, Ann N Y Acad Sci, 1014, 222, 10.1196/annals.1294.025

Mitry, 1999, Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin, Br J Cancer, 81, 1351, 10.1038/sj.bjc.6690325

Sun, 2005, Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281, J Clin Oncol, 23, 4897, 10.1200/JCO.2005.03.616

Bajetta, 2007, Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?, Cancer Chemother Pharmacol, 59, 637, 10.1007/s00280-006-0306-6

Esser, 2006, Comparison of ((177)Lu-DOTA(0),Tyr(3))octreotate and ((177)Lu-DOTA(0),Tyr(3))octreotide: which peptide is preferable for PRRT?, Eur J Nucl Med Mol Imaging, 33, 1346, 10.1007/s00259-006-0172-9

Van Essen, 2007, Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours, Acta Oncol, 46, 723, 10.1080/02841860701441848

O'Toole, 2005, Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours, Best Pract Res Clin Gastroenterol, 19, 585, 10.1016/j.bpg.2005.02.011

Mazzaglia, 2007, Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival, Surgery, 142, 10, 10.1016/j.surg.2007.01.036

van Vilsteren, 2006, Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival, Liver Transpl, 12, 448, 10.1002/lt.20702

Schurr, 2007, Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience, Ann Surg, 245, 273, 10.1097/01.sla.0000232556.24258.68

Hodul, 2006, The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas, Cancer Control, 13, 61, 10.1177/107327480601300109

Ducreux, 2000, The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors, Am J Gastroenterol, 95, 3276, 10.1111/j.1572-0241.2000.03210.x

Fazio, 2007, Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?, Ann Oncol, 18, 13, 10.1093/annonc/mdl144

Roche, 2003, Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors, Eur Radiol, 13, 136, 10.1007/s00330-002-1558-0

Chamberlain, 2000, Hepatic neuroendocrine metastases: does intervention alter outcomes?, J Am Coll Surg, 190, 432, 10.1016/S1072-7515(00)00222-2

Gupta, 2005, Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival, Cancer, 104, 1590, 10.1002/cncr.21389

Roche, 2004, Prognostic factors for chemoembolization in liver metastasis from endocrine tumors, Hepatogastroenterology, 51, 1751

Hong, 2006, New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer, Clin Cancer Res, 12, 2563, 10.1158/1078-0432.CCR-05-2225

Lewis, 2006, Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization, J Vasc Interv Radiol, 17, 1335, 10.1097/01.RVI.0000228416.21560.7F

Oken, 1982, Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 5, 649, 10.1097/00000421-198212000-00014

Soreide, 1992, Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors, Surgery, 111, 48

Arnold, 1996, Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours, Gut, 38, 430, 10.1136/gut.38.3.430

Moertel, 1994, The management of patients with advanced carcinoid tumors and islet cell carcinomas, Ann Intern Med, 120, 302, 10.7326/0003-4819-120-4-199402150-00008

Nobin, 1989, Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour, Acta Oncol, 28, 419, 10.3109/02841868909111216

Ruutiainen, 2007, Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver, J Vasc Interv Radiol, 18, 847, 10.1016/j.jvir.2007.04.018

de Baere, 1995, Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study, Radiology, 194, 165, 10.1148/radiology.194.1.7997545

de Baere, 1998, Modification of arterial and portal hemodynamic after injection of iodized oil in the hepatic artery: experimental study, J Vasc Interv Radiol, 9, 305, 10.1016/S1051-0443(98)70273-8

Johnson, 1991, Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol, J Hepatol, 13, 120, 10.1016/0168-8278(91)90873-A

Eriksson, 1998, Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors, Cancer, 83, 2293, 10.1002/(SICI)1097-0142(19981201)83:11<2293::AID-CNCR8>3.0.CO;2-E

Varela, 2007, Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics, J Hepatol, 46, 474, 10.1016/j.jhep.2006.10.020